TNSN98157A1 - 2-aminopyridines alkoxy-substituees nouvelles, compositions pharmaceutiques les contenant et procede pour leur preparation - Google Patents
2-aminopyridines alkoxy-substituees nouvelles, compositions pharmaceutiques les contenant et procede pour leur preparationInfo
- Publication number
- TNSN98157A1 TNSN98157A1 TNTNSN98157A TNSN98157A TNSN98157A1 TN SN98157 A1 TNSN98157 A1 TN SN98157A1 TN TNSN98157 A TNTNSN98157 A TN TNSN98157A TN SN98157 A TNSN98157 A TN SN98157A TN SN98157 A1 TNSN98157 A1 TN SN98157A1
- Authority
- TN
- Tunisia
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- aminopyridines
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Addiction (AREA)
- Otolaryngology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Abstract
L'INVENTION CONCERNE DES COMPOSES DE FORMULE DANS LAQUELLE X, R1, R2, R3 et R4 REPRESENTENT DIVERS RADICAUX. ELLE CONCERNE AUSSI UN PROCEDE POUR LEUR PREPARATION ET DES COMPOSITIONS PHARMACEUTIQUES LES CONTENANT. APPLICATION : UTILISATION DE CES COMPOSES ET COMPOSITIONS, PRESENTANT UNE ACTIVITE D'INHIBITEURS D'OXYDE NITRIQUE-SYNTHETASE (NOS), DANS LE TRAITEMENT ET LA PREVENTION DE MALADIES DU SYSTEME NERNEUX CENTRAL ET D'AUTRES AFFECTIONS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5773997P | 1997-08-28 | 1997-08-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN98157A1 true TNSN98157A1 (fr) | 2005-03-15 |
Family
ID=22012464
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNTNSN98157A TNSN98157A1 (fr) | 1997-08-28 | 1998-08-26 | 2-aminopyridines alkoxy-substituees nouvelles, compositions pharmaceutiques les contenant et procede pour leur preparation |
Country Status (32)
Country | Link |
---|---|
US (2) | US6362195B1 (fr) |
EP (1) | EP1007512B1 (fr) |
JP (1) | JP3441714B2 (fr) |
CN (1) | CN1268122A (fr) |
AP (1) | AP9801331A0 (fr) |
AR (1) | AR016644A1 (fr) |
AT (1) | ATE215532T1 (fr) |
AU (1) | AU8458698A (fr) |
BR (1) | BR9811921A (fr) |
CA (1) | CA2302436C (fr) |
DE (1) | DE69804635T2 (fr) |
DK (1) | DK1007512T3 (fr) |
EA (1) | EA200000165A1 (fr) |
ES (1) | ES2172173T3 (fr) |
GT (1) | GT199800135A (fr) |
HN (1) | HN1998000125A (fr) |
HR (1) | HRP980476A2 (fr) |
HU (1) | HUP0002803A2 (fr) |
ID (1) | ID24318A (fr) |
IL (1) | IL134302A0 (fr) |
IS (1) | IS5342A (fr) |
MA (1) | MA26538A1 (fr) |
NO (1) | NO20000957L (fr) |
OA (1) | OA11294A (fr) |
PA (1) | PA8458301A1 (fr) |
PE (1) | PE106699A1 (fr) |
PL (1) | PL339008A1 (fr) |
PT (1) | PT1007512E (fr) |
SI (1) | SI1007512T1 (fr) |
TN (1) | TNSN98157A1 (fr) |
WO (1) | WO1999011620A1 (fr) |
ZA (1) | ZA987788B (fr) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010049379A1 (en) | 1997-08-27 | 2001-12-06 | Lowe John Adams | 2-aminopyridines containing fused ring substituents |
BR9912906A (pt) * | 1998-08-11 | 2001-05-08 | Pfizer Prod Inc | Usos farmacêuticos para inibidores de nos |
TR200102481T2 (tr) * | 1999-02-25 | 2002-01-21 | Pfizer Products Inc. | Fazlı zincir muadili içeren 2-aminopiridinler. |
WO2001009307A2 (fr) * | 1999-07-30 | 2001-02-08 | University College London | Recherche systematique de modulateurs de synthase d'oxyde nitrique |
CA2380323A1 (fr) * | 1999-07-30 | 2001-02-08 | University College London | Criblage inductible pour la decouverte de medicaments |
GB0004153D0 (en) | 2000-02-23 | 2000-04-12 | Astrazeneca Uk Ltd | Novel use |
GB0004151D0 (en) * | 2000-02-23 | 2000-04-12 | Astrazeneca Uk Ltd | Novel use |
GB0004149D0 (en) | 2000-02-23 | 2000-04-12 | Astrazeneca Uk Ltd | Novel compounds |
GB0004152D0 (en) * | 2000-02-23 | 2000-04-12 | Astrazeneca Uk Ltd | Novel compounds |
US6469172B2 (en) * | 2000-03-08 | 2002-10-22 | Merck & Co., Inc. | Process for the preparation of chemical compounds |
SE0102640D0 (sv) | 2001-07-31 | 2001-07-31 | Astrazeneca Ab | Novel compounds |
US20040077853A1 (en) * | 2001-10-10 | 2004-04-22 | Pfizer Inc. | 2-amino-6-(2,4,5-substituted-phenyl)-pyridines |
WO2003092693A1 (fr) * | 2002-05-06 | 2003-11-13 | Washington University | Methodes de traitement du glaucome et d'autres etats induits par l'expression de nos-2 par inhibition de la voie egfr |
WO2005007627A1 (fr) * | 2003-07-18 | 2005-01-27 | Nihon Nohyaku Co., Ltd. | Derive de phenylpyridine, produit intermediaire correspondant, et herbicide contenant ledit derive de phenylpyridine en tant qu'ingredient actif |
US7919487B2 (en) * | 2004-11-10 | 2011-04-05 | Synta Pharmaceuticals Corporation | Heteroaryl compounds |
EP2027087A2 (fr) * | 2006-05-18 | 2009-02-25 | MannKind Corporation | Inhibiteurs de kinases intracellulaires |
UA105182C2 (ru) | 2008-07-03 | 2014-04-25 | Ньюрексон, Інк. | Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность |
EP3002279A1 (fr) | 2014-10-02 | 2016-04-06 | Bayer CropScience AG | Procédé de fabrication de dérivés de sulfure 3-(5-aminotriazolyl) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5892112A (en) * | 1990-11-21 | 1999-04-06 | Glycomed Incorporated | Process for preparing synthetic matrix metalloprotease inhibitors |
AU4515696A (en) * | 1994-12-12 | 1996-07-03 | Merck & Co., Inc. | Substituted 2-aminopyridines as inhibitors of nitric oxide synthase |
US5972975A (en) * | 1995-12-08 | 1999-10-26 | Merck & Co., Inc. | Substituted 2-aminopyridines as inhibitors of nitric oxide synthase |
WO1997027177A2 (fr) * | 1996-01-29 | 1997-07-31 | The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Derives de dihydropyridine-, pyridine-, benzopyrane- mono- et triazoloquinazoline, leur preparation, et utilsation comme antagonistes des recepteurs de l'adenosine |
DK0891332T3 (da) * | 1996-03-29 | 2004-07-05 | Pfizer | 6-phenylpyridyl-2-aminderivater |
HN1997000027A (es) | 1996-12-06 | 1997-06-05 | Pfizer Prod Inc | Derivados de 6-fenil piridil - 2 amina |
-
1998
- 1998-08-10 HN HN1998000125A patent/HN1998000125A/es unknown
- 1998-08-11 WO PCT/IB1998/001223 patent/WO1999011620A1/fr active IP Right Grant
- 1998-08-11 CA CA002302436A patent/CA2302436C/fr not_active Expired - Fee Related
- 1998-08-11 JP JP2000508660A patent/JP3441714B2/ja not_active Expired - Fee Related
- 1998-08-11 EA EA200000165A patent/EA200000165A1/ru unknown
- 1998-08-11 SI SI9830136T patent/SI1007512T1/xx unknown
- 1998-08-11 PL PL98339008A patent/PL339008A1/xx unknown
- 1998-08-11 US US09/381,887 patent/US6362195B1/en not_active Expired - Fee Related
- 1998-08-11 HU HU0002803A patent/HUP0002803A2/hu unknown
- 1998-08-11 IL IL13430298A patent/IL134302A0/xx unknown
- 1998-08-11 PT PT98935247T patent/PT1007512E/pt unknown
- 1998-08-11 ID IDW20000359A patent/ID24318A/id unknown
- 1998-08-11 DE DE69804635T patent/DE69804635T2/de not_active Expired - Fee Related
- 1998-08-11 DK DK98935247T patent/DK1007512T3/da active
- 1998-08-11 AU AU84586/98A patent/AU8458698A/en not_active Abandoned
- 1998-08-11 AT AT98935247T patent/ATE215532T1/de not_active IP Right Cessation
- 1998-08-11 CN CN98808459A patent/CN1268122A/zh active Pending
- 1998-08-11 BR BR9811921-4A patent/BR9811921A/pt not_active Application Discontinuation
- 1998-08-11 ES ES98935247T patent/ES2172173T3/es not_active Expired - Lifetime
- 1998-08-11 EP EP98935247A patent/EP1007512B1/fr not_active Expired - Lifetime
- 1998-08-17 GT GT199800135A patent/GT199800135A/es unknown
- 1998-08-24 PE PE1998000770A patent/PE106699A1/es not_active Application Discontinuation
- 1998-08-26 AR ARP980104258A patent/AR016644A1/es unknown
- 1998-08-26 PA PA19988458301A patent/PA8458301A1/es unknown
- 1998-08-26 TN TNTNSN98157A patent/TNSN98157A1/fr unknown
- 1998-08-26 MA MA25230A patent/MA26538A1/fr unknown
- 1998-08-27 AP APAP/P/1998/001331A patent/AP9801331A0/en unknown
- 1998-08-27 ZA ZA9807788A patent/ZA987788B/xx unknown
- 1998-08-28 HR HR60/057,739A patent/HRP980476A2/hr not_active Application Discontinuation
-
2000
- 2000-01-14 IS IS5342A patent/IS5342A/is unknown
- 2000-02-25 OA OA1200000053A patent/OA11294A/en unknown
- 2000-02-25 NO NO20000957A patent/NO20000957L/no not_active Application Discontinuation
-
2001
- 2001-09-20 US US09/957,398 patent/US20020022642A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN98154A1 (fr) | Derives de 2-aminopyridine nouveaux et compositions pharmaceutiques les contenant | |
TNSN97055A1 (fr) | Derives de 6-phenylpyridyl -2- amine, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
TNSN98157A1 (fr) | 2-aminopyridines alkoxy-substituees nouvelles, compositions pharmaceutiques les contenant et procede pour leur preparation | |
TNSN99155A1 (fr) | 1-aryl-3-arylmethyl-1,8-naphtyridine-4(1h)-ones nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN96172A1 (fr) | Composes heterocycliques, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
TNSN97198A1 (fr) | Derives de 6-phenylpyridyl-2- amine et compositions pharmaceutiques les contenant | |
TNSN98035A1 (fr) | Atropisomeres de 3-aryl-4(3h)-quinazolinones, procede pour leur preparation et compositions les contenant | |
TNSN98024A1 (fr) | 2-amino-6-(2-substitue-4-phenoxy)-substitue-pyridines, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
TNSN99169A1 (fr) | Derives de 4,4-biarylpiperidine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN99171A1 (fr) | 4-carboxyamino-2-substitue-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN99073A1 (fr) | Pyrazolopyrimidinones nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN99110A1 (fr) | Inhibiteurs non peptidiques de l'adhesion cellulaire sous la dependance de vla-4, procede pour leur preparation et compositions pharmaceutiques les contenant | |
MA26697A1 (fr) | Composes nouveaux inhibiteurs de gsk-3 et compositions pharmaceutiques les contenant | |
TNSN98045A1 (fr) | Derives de nicotinamide nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
TNSN98112A1 (fr) | Composes dipeptidiques | |
TNSN99236A1 (fr) | Derives bicycliques substitues nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
TNSN98150A1 (fr) | Derives d'acides aryloxyarylsulfonylaminohydroxamiques ; procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN97087A1 (fr) | 4(3h)-quinazolinones 2,3-disubstituees nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN99006A1 (fr) | 4-(2-ceto-1-benzimidazolinyl) piperidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN98053A1 (fr) | Pyrazolopyrimidinones nouvelles, procede pour leur preparation et compositions les contenant. | |
TNSN00028A1 (fr) | Derives de quinoleine -2-one a substituant heteroaryle nouveaux procede pour leur preparation et compositions pharmaceutiques les contenant. | |
MA26723A1 (fr) | Acides oxamiques nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
TNSN99147A1 (fr) | Procede d'emulsification | |
TNSN99253A1 (fr) | Composes chimiques nouveaux modulateurs de ccr5, et compositions pharmaceutiques les contenant. | |
TNSN97139A1 (fr) | Derives d'acides d'arylsulfonylaminohydroxamiques |